Would you give prophylactic nitrofurantoin to a prospective kidney donor with an active uncomplicated urinary tract infection?

Prophylactic Nitrofurantoin in Prospective Kidney Donors with Active UTI

Do not give prophylactic nitrofurantoin to a prospective kidney donor with an active uncomplicated urinary tract infection—treat the active infection first with a full therapeutic course (5-7 days), then defer donation until the infection is completely resolved. 1

Why This Approach Is Mandatory

Active Infection Requires Treatment, Not Prophylaxis

• An active symptomatic UTI is not an indication for prophylaxis; it requires full therapeutic treatment. Nitrofurantoin 100 mg twice daily for 5 days is the recommended first-line therapeutic regimen for uncomplicated cystitis 1, 2
• Prophylaxis is defined as prevention of future infections in patients with recurrent UTI (≥2 infections in 6 months or ≥3 in 12 months), not treatment of current infection 1
• The distinction is critical: therapeutic dosing aims to eradicate active infection, while prophylactic dosing (typically 50-100 mg once daily) is subtherapeutic and will fail to clear the current infection 1, 3

Kidney Donation Requires Complete Resolution

• All major transplant guidelines require that active infections be completely treated and resolved before proceeding with living donor nephrectomy 1
• Performing nephrectomy on a donor with active bacteriuria risks:
  • Intraoperative bacteremia and sepsis
  • Transmission of infection to the recipient
  • Increased surgical site infection risk
  • Compromised donor safety 1

The Correct Management Algorithm

Step 1: Confirm the diagnosis

• Obtain urine culture before starting antibiotics to document the pathogen and susceptibility 1, 2
• Ensure the infection is truly uncomplicated (no fever, flank pain, systemic symptoms, or structural abnormalities) 1

Step 2: Treat the active infection therapeutically

• Nitrofurantoin 100 mg orally twice daily for 5 days (first-line) 1, 2
• Alternative first-line options if nitrofurantoin is contraindicated:
  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (only if local E. coli resistance <20%) 1, 2
  • Fosfomycin 3 g single dose 1, 2

Step 3: Defer donation until complete resolution

• Wait at least 2-4 weeks after completing treatment before proceeding with donor evaluation 1
• Obtain a repeat urine culture to document clearance of bacteriuria 1
• Ensure the donor is completely asymptomatic 1

Step 4: Reassess for underlying risk factors

• If the donor has recurrent UTIs (≥2 in 6 months), this may warrant further evaluation before proceeding with donation 1
• Consider whether the donor has modifiable risk factors (e.g., sexual activity patterns, inadequate hydration) that should be addressed 1

When Prophylactic Nitrofurantoin Would Be Appropriate (But Not in This Case)

Prophylactic nitrofurantoin is indicated for:

• Women with recurrent uncomplicated UTIs (≥2 in 6 months or ≥3 in 12 months) who have failed behavioral modifications 1
• Post-coital prophylaxis in women whose UTIs are temporally related to sexual activity 1
• Typical prophylactic dosing: 50-100 mg once daily or 100 mg post-coitally 1, 3
• Duration: typically 6-12 months with periodic reassessment 1

Prophylactic nitrofurantoin is NOT indicated for:

• Treatment of active symptomatic UTI 1, 2
• Asymptomatic bacteriuria (except in pregnancy) 1, 2
• Single isolated UTI without recurrence 1

Critical Safety Considerations for Nitrofurantoin

Contraindications That May Affect Donor Candidacy

• Creatinine clearance <30-60 mL/min is an absolute contraindication because therapeutic urinary concentrations cannot be achieved 1, 2
• If the prospective donor has any degree of renal impairment, nitrofurantoin should not be used even for treatment 1
• Pregnancy (last trimester), G6PD deficiency, and significant hepatic impairment are additional contraindications 1

Adverse Event Profile

• Serious pulmonary and hepatic toxicity rates are extremely low (0.001% and 0.0003% respectively) with short-term therapeutic use 1
• Risk increases substantially with long-term prophylactic use (>6 months), with severe adverse effects occurring in 0.02-1.5 per 1000 users in cohort studies 3
• Common minor adverse effects include gastrointestinal disturbances and rash 1
• Acute pulmonary reactions can occur as early as day 4-8 of therapy and may recur upon rechallenge 4

Common Pitfalls to Avoid

• Do not confuse "prophylaxis" with "treatment"—an active infection requires full therapeutic dosing, not prophylactic dosing 1, 2
• Do not proceed with donor nephrectomy while the donor has active bacteriuria—this violates fundamental transplant safety principles 1
• Do not use nitrofurantoin for febrile UTI or suspected pyelonephritis—it does not achieve adequate tissue concentrations 1, 2
• Do not prescribe nitrofurantoin if the donor has any renal impairment—therapeutic levels will not be achieved 1, 2
• Do not treat asymptomatic bacteriuria discovered incidentally during donor workup—this increases resistance without benefit (unless the donor is pregnant) 1, 2

Summary: The Answer Is "Treat First, Then Defer"

The correct approach is to treat the active UTI with therapeutic-dose nitrofurantoin (100 mg twice daily for 5 days), document complete resolution with repeat culture, and defer donation for at least 2-4 weeks. Prophylactic nitrofurantoin has no role in this scenario because the patient has an active infection requiring treatment, not prevention. 1, 2